Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Budesonide, Symbicort and Triple Nebulized Drugs in Perioperative Airway Function for Chronic Sinusitis
ChiCTR2100048845Phase 4Recruiting
- Sponsor
- Yantai Yuhuangding Hospital
- Start
- Jul 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of budesonide in chronic rhinosinusitis (CRS) (3 arms), sponsored by Yantai Yuhuangding Hospital. Primary endpoint: Lung function. Started Jul 2021; status: recruiting.
02
Drugs
budesonide
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on ChiCTR2100048845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048845.